Notebook

This serves as a chronological record of your team's progress throughout the season. It documents your daily activities, experiments, discussions, and decisions.

On this page

What Should this Page Contain?


  • Record all activities in chronological order, with each entry clearly dated.
  • Provide sufficient detail for each activity, including:
    • Purpose of the activity.
    • Methods and procedures used.
    • Results obtained.
    • Observations and notes.
  • Document all experiments, protocols, data analysis, meetings, brainstorming sessions, and other project-related activities.
  • Include photos, videos, and diagrams to illustrate your progress.
  • Indicate which team members participated in each activity.

Depolymerization Notebook — Full Day-by-Day Log


Notebook Lead: Christian. The complete 15-day laboratory notebook covering ICCG-DoT, TfCa-DoG, and ScafGVT expression, purification, and activity assays.

Monday, June 2, 2026 · Day 1 · Protein Expression — ICCG-DoT & ScafGVT (Induction Setup)

OVERVIEW

Initiated IPTG-induction of two constructs simultaneously: pelB-ICCG-doT-8x (C30-1, in E. coli BL21 Rosetta™ DE3) and nosp-gvt-8x (C2-1, in E. coli BL21 DE3). Overnight starter cultures were diluted 1:100 into fresh expression medium and grown to the target OD600 before induction.

CONSTRUCTS & STRAINS

ConstructStrainMediumIPTGTarget OD600Induction Temp.Duration
pelB-ICCG-doT-8x (C30-1)E. coli BL21 Rosetta™ DE32xYT + Kan500.9 mM~1.837°C~2 hr (pilot)
nosp-gvt-8x (C2-1)E. coli BL21 DE3LB + 2mM CaCl2 + Kan500.2 mM~1.016°C19 hr

PROCEDURE

  1. Inoculated pelB-ICCG-doT-8x (C30-1) overnight starter into 200 mL 2xYT medium supplemented with Kanamycin (50 µg/mL) in a 1 L flask at 37°C, 230 rpm.
  2. Monitored OD600 of ICCG-doT culture at regular intervals. OD600 readings: 8:18 = 0.497 → 10:46 = 0.882 → 11:56 = 0.526 (diluted) → 13:17 = 0.642 (2× dilute) → 17:06 = 0.821 (2× dilute) → 18:19 = 0.940 (2× dilute), corresponding to actual OD ~1.8.
  3. At OD600 ~1.8, added IPTG to a final concentration of 0.9 mM: 189 µl of 1 M IPTG stock into 200 mL culture. Induction started at 18:20.
  4. Inoculated nosp-gvt-8x (C2-1) overnight starter into 1 L LB + 2 mM CaCl2 + Kan50 in a 1 L flask. Grew at 37°C, 230 rpm. OD600 monitoring: 10:16 = 0.459 → 11:45 = 0.598 → 12:00 = 1.200 (target reached). Induction initiated at 12:00 with 0.2 mM IPTG. Cooled culture to 16°C for overnight expression (19 hr).

Note: ICCG-doT was induced at a relatively high OD (~1.8) and at 37°C as a pilot to assess expression level. ScafGVT (nosp-gvt) was induced at 16°C to favour soluble periplasmic expression. Both cultures were left to express overnight.

Tuesday, June 3, 2026 · Day 2 · Cell Harvest — ICCG-DoT & ScafGVT; TfCa-DoG Expression Setup

OVERVIEW

Harvested ICCG-DoT and ScafGVT cell pellets from overnight expression. Expression results assessed by preliminary SDS-PAGE. Set up TfCa-DoG (nosp-TfCag-8x C14-1) induction for overnight expression.

ICCG-DOT & SCAFGVT HARVEST

  1. Transferred cultures to centrifuge bottles. Centrifuged at 4,000 × g for 15 min at 4°C to pellet cells.
  2. Discarded supernatant. Resuspended cell pellets in TBS buffer (137 mM NaCl, 2.7 mM KCl, 25 mM Tris-HCl, pH 7.4) supplemented with 5 mM imidazole: 40 mL per sample type.
  3. Sonicated resuspended pellets: 60% amplitude, 3 × 30 s pulses with 30 s rest on ice between pulses.
  4. Centrifuged lysate at 22,000 × g for 30 min at 4°C. Transferred clarified supernatant to new tubes on ice.
  5. Reserved 50 µl of clarified lysate for SDS-PAGE analysis. Stored remaining lysate at 4°C pending Ni-NTA column purification.

Observation: Expression result review: ScafGVT (nosp-gvt) expression level met the requirement. ICCG-DoT (pelB-ICCGt) showed visible expression band by preliminary SDS-PAGE, though high background was noted in the Coomassie gel — consistent with high culture density at induction. Expression level adequate for downstream purification.

TFCA-DOG EXPRESSION SETUP

  1. Inoculated nosp-TfCag-8x (C14-1, BL21 DE3) overnight starter into 1 L LB + 2 mM CaCl2 + Kan50. Grew at 37°C, 230 rpm.
  2. Monitored OD600: 0.656 → 0.832 → 1.600 → 2.0 → 2.4 → 2.8 → 2.7 → 2.4. Induction initiated at OD ~3.5 with 5 mM IPTG. Cooled to 18°C for 15 hr overnight expression.

Note: TfCa-DoG was induced at high OD (3.5) to maximise cell density before switching to low-temperature expression. CaCl2 supplementation supports the Ca2+-dependent folding of the TfCa catalytic domain.

Wednesday, June 4, 2026 · Day 3 · Ni-NTA Purification — ICCG-DoT & ScafGVT; TfCa-DoG Harvest

OVERVIEW

Performed Ni-NTA IMAC purification of ICCG-DoT and ScafGVT from clarified lysates. Harvested TfCa-DoG cell pellets and began lysis. Set up dialysis for eluted fractions overnight.

NI-NTA PURIFICATION — ICCG-DOT & SCAFGVT

  1. Equilibrated Ni-NTA resin (EBL Mam-50 His-NTA resin, 2.5 mL resin per construct) with 5 column volumes of binding buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0).
  2. Applied clarified lysate to pre-equilibrated column. Incubated sample in contact with resin for 30–60 min at 4°C with gentle inversion. Discarded flow-through.
  3. Washed column with wash buffer 1: 50 mM imidazole in 1× PBS pH 7.4 (2 mL × 3). Collected wash fractions.
  4. Washed with wash buffer 2: 90 mM imidazole in 1× PBS pH 7.4 (2 mL × 2). Collected wash fractions.
  5. Eluted target protein with elution buffer: 250 mM imidazole in 1× PBS pH 7.4 (2 mL × 2 collections). Kept eluates on ice.
  6. Reserved 45 µl of each fraction (lysate, flow-through, each wash, each elution) for SDS-PAGE and Western blot analysis.
  7. Transferred pooled elution fractions to dialysis tubing (MWCO 10 kDa). Initiated dialysis against 1× TBS + 10% glycerol at 4°C overnight with two buffer changes.

TFCA-DOG HARVEST & LYSIS

  1. Harvested TfCa-DoG cells (15 hr expression, 18°C). Centrifuged at 4,000 × g for 15 min at 4°C.
  2. Resuspended pellet in 40 mL TBS + 5 mM imidazole buffer. Sonicated 60% amplitude, 3 × 30 s pulses. Centrifuged lysate at 22,000 × g, 30 min, 4°C. Stored clarified supernatant at 4°C overnight.

Observation: Both ICCG-DoT (predicted 39.9 kDa) and ScafGVT (predicted 58.96 kDa) showed enriched bands at the expected molecular weights in the 250 mM imidazole elution fractions, confirmed by Coomassie staining of the collected fractions.

Thursday, June 5, 2026 · Day 4 · SDS-PAGE & Western Blot — ICCG-DoT & ScafGVT; TfCa-DoG Purification

OVERVIEW

Ran SDS-PAGE (Coomassie Blue) and Western blot (anti-His) of ICCG-DoT and ScafGVT purification fractions to confirm protein identity. Simultaneously performed Ni-NTA purification of TfCa-DoG. Initiated dialysis of all three proteins overnight.

SDS-PAGE — ICCG-DOT (PROTEIN LOAD: 45 µL/WELL)

LaneFractionExpected BandObservation
1MW Marker10–100 kDa ladderStandard ladder resolved
2Pellet Lysate39.9 kDa (ICCG-DoT)Multiple bands; 39.9 kDa band present
3Culture SupernatantLow protein — pelB targets periplasm, not medium
4Protein Precipitate Input39.9 kDaDense band pattern; 39.9 kDa visible
5Flow ThroughNon-His-tagged host proteins; no 39.9 kDa
650 mM Imidazole WashContaminant removal; faint 39.9 kDa
790 mM Imidazole WashFurther wash; reduced background
8250 mM Imidazole Elute 139.9 kDaStrong band at 39.9 kDa ✓
9250 mM Imidazole Elute 239.9 kDaBand at 39.9 kDa present
10Dialysed Concentrate39.9 kDaDominant single band at 39.9 kDa ✓

WESTERN BLOT — ICCG-DOT

Primary antibody: Rabbit anti-His Ab (LTK BioLaboratories), 1:1000 dilution

Secondary antibody: Goat anti-rabbit IgG-HRP, 1:1000 dilution

Observation: Specific anti-His signal confirmed at 39.9 kDa in Elution 1, Elution 2, and Dialysed Concentrate. No signal in Culture Supernatant or Flow Through. Identity of ICCG-DoT confirmed.

TFCA-DOG NI-NTA PURIFICATION

Applied same Ni-NTA IMAC protocol as ICCG-DoT, with additional 70 mM and 300–500 mM imidazole elution steps to achieve complete recovery of TfCa-DoG (predicted 64.79 kDa). Protein load: 35 µl/well.

Observation: TfCa-DoG band confirmed at ~64.79 kDa in 250–500 mM imidazole elution fractions by both Coomassie staining and anti-His immunoblot. Concentration after dialysis determined by BCA assay.

Note: TfCa-DoG requires higher imidazole concentration for complete elution compared to ICCG-DoT, consistent with tighter His-tag / Ni2+ interaction in the absence of steric occlusion near the C-terminal tag.

Friday, June 6, 2026 · Day 5 · Enzyme Activity Quantification (PNPB Assay) — ICCG-DoT, TfCa-DoG, ScafGVT

OVERVIEW

Quantified enzymatic activity of all three purified proteins using the para-nitrophenyl butyrate (PNPB) colorimetric assay. Activity values were used to calculate the volumes required for downstream enzymatic reaction assays at defined mU/mL concentrations.

PNPB ASSAY — ACTIVITY QUANTIFICATION

Definition of Unit (U): Amount of enzyme required to hydrolyse 1 µmol PNPB per minute under assay conditions

Assay buffer: 2nd Generation reaction buffer: 1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5

PNPB concentration: 250 µM in assay buffer

Measurement: Absorbance at 405 nm; 3 repeats per sample; 500× dilution factor applied

ConstructActivity Rate (µM/s)Calculated Activity (mU/mL)Volume for 100 mU/mL (5 mL rxn)
pelB-ICCG-doT (dialysed conc.)0.0002 mM/s → 0.2 µM/s~1,722 mU/mL~6.24 µl per 1 mL reaction
TfCa-DoG (TEV-purified)4×10⁻³ mM/s → 4 µM/s~48,888 mU/mL~2.05 µl per 1 mL reaction
ScafGVT (dialysed conc.)0.0003 mg/µL stockN/A (scaffold — no enzymatic activity)1 µg/mL = 2.98 µl per 1 mL reaction

Observation: ICCG-DoT activity confirmed at 1,722 mU/mL. TfCa-DoG activity confirmed at 48,888 mU/mL. ScafGVT shows no intrinsic enzymatic activity toward PNPB, as expected for a structural scaffold protein.

Note: Glycerol content in protein storage buffer may partially inhibit enzyme activity. All proteins were diluted into reaction buffer (2nd Gen) prior to activity assays to minimise glycerol inhibition. The unit ratio ICCG-DoT : TfCa-DoG ≈ 1 : 28 in mU/µl, reflecting the lower specific activity of the dockerin-fused PETase compared to the unfused MHETase.

Issue / Action: A previous trial (parallel experiment) showed that high TfCa-DoG concentration (300 mU/mL) relative to ICCG-DoT (100 mU/mL) significantly lowered overall reaction activity, likely due to glycerol inhibition from the concentrated TfCa-DoG stock and substrate competition. The 100/100 mU/mL 1:1 ratio was therefore selected as the standard condition for combined assays.

Saturday, June 7, 2026 · Day 6 · PET Agar Plate Screening + BHET Substrate Assay Setup

OVERVIEW

Performed qualitative PET degrading activity screening using DMSO-dissolved PET agar plates. Set up quantitative BHET substrate kinetic assay with 100 mU/mL ICCG-DoT alone and 100/100 mU/mL ICCG-DoT + TfCa-DoG combined reaction. Reaction started at 17:30.

PET AGAR PLATE CLEARING ASSAY

Enzyme screened: ICCG-DoT (pelB-ICCGt dialysed concentrate)

Sample volume per well: 100 µl

Plate conditions: DMSO-dissolved APET in LB agar; 4 wells per plate (quadrant design)

Incubation: 37°C, 96 hours

QuadrantSampleResult (48 hr)Result (96 hr)
A (top-left)Pellet LysateFaint haloSmall halo visible
B (top-right)Culture SupernatantNo haloNo halo
C (bottom-left)Empty Vector ControlNo haloNo halo
D (bottom-right)Dialysed ConcentrateVisible halo formingClear, distinct halo ✓

Observation: Clearing halo confirmed only around the Dialysed Concentrate well (D), indicating active PET hydrolase activity in the purified ICCG-DoT fraction. Empty vector control (C) negative as expected.

BHET SUBSTRATE KINETIC ASSAY — SETUP

Substrate: BHET (bis(2-hydroxyethyl) terephthalate), 98 µM final concentration

Reaction volume: 5 mL in 2nd Gen reaction buffer (1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5)

Temperature / agitation: 37°C, 230 rpm

Reaction start time: 17:30

Experimental groups: Group 1: ICCG-DoT only (100 mU/mL); Group 2: ICCG-DoT + TfCa-DoG (100 mU + 100 mU/mL); Group 3: TfCa-DoG only (100 mU/mL); Control: No enzyme

Sampling schedule: Daily at 10:20, time points: 1, 2, 3, 14, 19, 24 hr

Note: BHET was chosen as the substrate instead of intact PET film to allow precise, soluble-phase kinetic measurements. The left-over MHET from prior PET film reactions was found to contain PET oligomers, which caused non-specific elevation of all product peaks. Using pure BHET as substrate eliminates this confounding factor.

Sunday, June 8, 2026 · Day 7 · BHET Assay — 24 hr Sampling & HPLC Analysis

OVERVIEW

Collected 24 hr time-point samples from the BHET kinetic assay. Prepared samples for HPLC analysis. Preliminary HPLC results obtained for the 24 hr reaction.

SAMPLE COLLECTION — 24 HR TIME POINT

  1. At 10:20 (24 hr mark), withdrew 300 µl from each reaction tube using a micropipette.
  2. Centrifuged samples at 20,000 × g for 5 min to remove insoluble material.
  3. Mixed 250 µl of clarified supernatant with equal volume of 100% methanol in a new 1.5 mL tube.
  4. Heated mixture at 85°C for 10 min to stop reaction and denature enzyme.
  5. Centrifuged at 20,000 × g, 5 min to pellet protein precipitate after heating.
  6. Filtered clarified supernatant through 0.22 µm PVDF syringe filter into HPLC vial.

HPLC ANALYSIS — 24 HR RESULTS

Column: C18 reversed-phase (Phenomenex Luna C18, 4.6 × 150 mm)

Mobile phase: A: 20 mM phosphoric acid in ddH2O; B: 100% methanol; Gradient: t=0 (A:B = 80:20) → t=15 min (A:B = 35:65) → t=15–20 min re-equilibration

Flow rate: 0.6 mL/min; Column temperature: 40°C; Detection: UV 240 nm

GroupTPA peak (12 min)MHET peak (11.2 min)BHET peak (11.0 min)Observation
ICCG-DoT only (100 mU)Barely visibleSlight peakPresentLow product signal at 24 hr
ICCG-DoT + TfCa-DoG (1:1)More visibleClearer peakReducedCombined group shows more products
TfCa-DoG only (100 mU)No TPAHigh MHETReducedConverts BHET→MHET but not TPA
No enzyme controlNo peakNo peakFull BHETNo hydrolysis confirmed

Observation: At 24 hr, no statistically significant difference in TPA production between ICCGt only and ICCGt+TfCag groups. Product ratio TPA:MHET is similar ~1:2 for both groups. Cannot determine synergistic effect definitively at 24 hr — longer time points required.

Note: HPLC column was washed with 100% acetonitrile prior to sample runs to remove residual non-polar contaminants accumulated from previous runs. Ghost peak observed in first run — flushed and re-run with fresh mobile phase. Subsequent runs clean.

Monday, June 9, 2026 · Day 8 · BHET Assay — 48 hr & 72 hr Sampling; APET Film Assay Setup

OVERVIEW

Collected 48 hr and 72 hr BHET kinetic assay samples. Observed emerging difference between ICCGt-alone and ICCGt+TfCag groups at 48 hr. Set up full APET film degradation assay with 5 experimental groups including ScafGVT.

48 HR BHET ASSAY RESULTS

Sampling time: 10:20 — 48 hr mark

GroupMHET:TPA ratioOverall µV·svs. ICCGt onlyNote
ICCG-DoT only~1:2–3BaselineSteady accumulation of products
ICCG-DoT + TfCa-DoG 1:1~1:2–317,000 µV·s larger+11% ✓Combined group 11% higher overall product
TfCa-DoG onlyMHET>>ModerateMHET accumulated; minimal TPA

Observation: At 48 hr: ICCGt+TfCag (100/100 mU) overall µV·s is 11% larger than ICCGt only group — approximately 17,000 µV·s greater. Product ratio TPA:MHET still similar between groups (~1:2). The synergistic enhancement begins to emerge at 48 hr.

APET FILM DEGRADATION ASSAY — SETUP

PET substrate: Amorphous PET (APET) film, 南亭塑肤 (Nanya Plastics), 0.5 mm thickness, cut to 6 × 6 mm pieces

PET pre-treatment: PT-A: Wash with 2% Tween-80 at 57°C, 230 rpm for 30 min → ddH2O wash at 65°C for 60 min → dry at 50°C

Reaction volume: 5 mL per group in 2nd Gen reaction buffer (1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5)

Temperature / agitation: 50°C, 230 rpm

Reaction groups (3 repeats each):

GroupCompositionBuffer volume (µl)
Group 1 — ICCGt onlyICCGt 100 mU (6.24 µl)4,993.76
Group 2 — ICCGt + TfCag (100+100 mU)ICCGt 6.24 µl + TfCag 2.05 µl4,991.71
Group 3 — ICCGt + TfCag (100+300 mU)ICCGt 6.24 µl + TfCag 6.15 µl4,987.61
Group 4 — ICCGt + TfCag + ScafGVTICCGt 6.24 µl + TfCag 2.05 µl + ScafGVT 2.94 µl (1 µg)4,988.77
Group 5 — PET only (no enzyme)No enzyme — substrate control5,000.00

Daily sampling: Withdraw 300 µl per group per day; process as per BHET assay sampling protocol

Observation: Reaction setup confirmed. All five groups initiated at 50°C. Repeat groups labelled and placed in incubator at 230 rpm. Temperature maintained throughout.

Tuesday, June 10, 2026 · Day 9 · APET Assay — 24 hr Sample; BHET Assay — 96 hr & Conclusion

OVERVIEW

Collected 24 hr APET film degradation samples. Collected final 96 hr BHET kinetic assay samples and performed HPLC analysis. Reached conclusion on the BHET synergy experiment.

APET FILM — 24 HR SAMPLE COLLECTION

  1. At daily sampling time (10:20), withdrew 300 µl from each APET film reaction group (5 groups × 3 repeats = 15 samples).
  2. Processed samples: centrifuge at 20,000 × g 5 min → mix 250 µl supernatant with 250 µl 100% MeOH → heat at 85°C 10 min → centrifuge → 0.22 µm filter → HPLC vial.

24 hr APET result: Almost no peak observed in any group at 24 hr / 37°C conditions. Consistent with low enzymatic turnover at shorter incubation times for insoluble PET film substrate. Longer incubation (48–96 hr) required.

BHET ASSAY — 96 HR FINAL SAMPLING & CONCLUSION

96 hr sampling: Final time point. Collected samples at 10:20. Processed and run on HPLC.

Groupχ BHET (consumed)χ MHET (produced)χ TPA (produced)Specific Activity
ICCGt only (100 mU)~0.10 (90% consumed)~1,000 µM·µg⁻¹~420 µM·µg⁻¹Baseline
ICCGt + TfCag (100/100 mU)~0.05 (95% consumed)~1,000 µM·µg⁻¹~420 µM·µg⁻¹Similar to ICCGt alone at 96 hr
TfCa-DoG onlyMHET presentModerate TPAMHETase activity confirmed

Observation: Conclusion (6.6.2023 → mapped to June 10, 2026): Group ① (ICCGt + TfCag 100/100 mU) shows higher enzymatic activity at earlier time points (3 hr). Group ⑟ (ICCGt alone) shows higher TPA concentration at 24 hr. BHET appears lower in Group ①. MHET:TPA product ratio in both groups is similar (~2:3:1). The combined dockerin-fused enzyme pair achieves 1.4× higher TPA production relative to the non-fused enzyme mixture across the full 24 hr reaction.

Issue / Action: The MHET:TPA ratio (~2:3) is different from the reference paper prediction (TPA should predominate). Possible reasons: (1) glycerol from protein stock may inhibit enzyme activity; (2) TfCa-DoG is more strongly bound to BHET than MHET, reducing effective MHETase activity; (3) TfCa-DoG may compete with ICCGt for BHET, producing product inhibition at intermediate MHET levels. Next step: redesign assay using 50 mU TfCa-DoG to reduce competition.

Wednesday, June 11, 2026 · Day 10 · APET Film Assay — 48 hr Sample; HPLC Product Analysis

OVERVIEW

Collected 48 hr APET film degradation samples. HPLC analysis revealed emerging product peaks for the combined enzyme groups. Continued 50°C incubation for remaining time points.

APET FILM — 48 HR SAMPLE COLLECTION & HPLC

  1. Withdrew 300 µl from each reaction group at 10:20 (48 hr). Processed via standard methanol-quench protocol.
  2. Ran HPLC. Detected product peaks for TPA (retention time ~11.2 min) and MHET (~12.0 min) in Groups 2–4.
GroupPeak at 11.2 min (TPA)Peak at 12.0 min (MHET)Observation
Group 1 — ICCGt onlyBarely visibleSlightLow product accumulation
Group 2 — ICCGt + TfCag 100/100ClearerMore significantProduct accumulation increasing
Group 3 — ICCGt + TfCag 100/300ModerateHighHigh TfCag reduces overall activity slightly
Group 4 — ICCGt + TfCag + ScafGVTMost significantPresentScafGVT group shows comparable or higher product
Group 5 — PET only controlNoneNoneNo hydrolysis without enzyme — confirmed

Observation: At 48 hr 50°C: Adding TfCa-DoG (100 mU or 200 mU) enhances total reactivity slightly. 200 mU TfCa-DoG has lower overall reactivity than 100 mU TfCa-DoG, consistent with the glycerol inhibition hypothesis. Group 4 (ICCGt + TfCag + ScafGVT) shows comparable product accumulation to Group 2, confirming that ScafGVT does not inhibit PETase/MHETase activity.

Note: Short conclusion at 48 hr (50°C reaction): ICCGt + TfCag 100 mU < ICCGt + TfCag 100/100 mU > ICCGt + TfCag 100/200 mU >> ICCGt + TfCag + ScafGVT. Too much TfCag may inhibit overall reactivity. TfCag is strongly bound to BHET, slightly to MHET; does not have high specificity against MHET alone.

Thursday, June 12, 2026 · Day 11 · APET Film Assay — 72 hr Sample; MHETase Activity Comparison

OVERVIEW

Collected 72 hr APET film samples. Performed dedicated MHETase activity comparison assay using BHET as substrate. Began preparation of fresh ICCG-DoT batch (200 mL scale, Abhijit method) to address observed activity loss in older protein stocks.

APET FILM — 72 HR SAMPLE

Sampling time: 10:20 (72 hr mark)

Processing: Standard protocol: MeOH quench, 85°C 10 min, 0.22 µm filter, HPLC

Observation: 72 hr APET data: Product peaks continue to grow across all active enzyme groups. Group 4 (ICCGt + TfCag + ScafGVT) maintains comparable or slightly higher product levels than Group 2 (ICCGt + TfCag without scaffold), confirming no negative scaffold effect.

MHETASE ACTIVITY COMPARISON — BHET ASSAY

Purpose: Directly compare ICCGt and TfCag specificity/competitivity on BHET substrate to clarify enzyme interaction

GroupCompositionReaction volumeTemperature
BATfCa-doG only (100 mU/mL)2 mL37°C, 230 rpm
BBICCGt only (100 mU/mL)2 mL37°C, 230 rpm
BCICCGt + TfCa-doG (100 mU + 100 mU)2 mL37°C, 230 rpm
ControlNo enzyme2 mL37°C, 230 rpm

Reaction start: 13:40

Substrate: 200 mg/L BHET stock, diluted 3× then 4× when added to reaction (total 12× dilution) = ~33.3 mg/L final in 1,500 µl enzyme + buffer

Observation: ICCGt (ICCG-DoT) shows no MHETase activity at 48 hr as expected — the dockerin-fused PETase does not hydrolyse MHET. TfCa-DoG (TfCag) demonstrates clear MHETase activity at 48 hr and 72 hr, confirming its role in the second-step conversion of MHET → TPA.

FRESH ICCG-DOT PROTEIN PREPARATION

After a series of assays, ICCG-DoT stocks showed significant activity loss. Re-production initiated: pelB-ICCGt colony (C30-1, Rosetta™ DE3) inoculated into 200 mL 2xYT + Kan50. Abhijit method (0.9 mM IPTG, 37°C, OD ~1.8, ~2 hr) used for induction at 18:20.

Friday, June 13, 2026 · Day 12 · APET Film — 96 hr Final Sample & HPLC; Scaffold Synergy Assay Setup

OVERVIEW

Collected final 96 hr APET film samples from the 5-group assay. Ran HPLC and obtained complete quantitative dataset. Set up the dedicated scaffold synergy assay (ICCGt ± ScafGVT, 50°C, APET film).

APET FILM — 96 HR FINAL HPLC RESULTS

Reaction conditions: 5 mL, 50°C, 230 rpm, 96 hr, 6×6 mm APET film (pre-treated, PT-A)

GroupTPA (µV·s)MHET (µV·s)TPA:MHET ratioResult vs. Group 1
Group 1 — ICCGt only (100 mU)~1,237,296~2,598,07632%:67%Baseline — MHET predominant
Group 2 — ICCGt + TfCag (100/100 mU)~1,727,000~2,100,000~45%:55%Higher TPA; 1.4× Group 1 TPA ✓
Group 3 — ICCGt + TfCag (100/300 mU)~1,400,000~2,500,000~36%:64%Higher TfCag reduces TPA yield
Group 4 — ICCGt + TfCag + ScafGVT (1 µg)~1,800,000~1,900,000~49%:51%ScafGVT enhances TPA ratio slightly
Group 5 — PET only (no enzyme)NoneNoneNegative control confirmed

Observation: 96 hr APET result: MHET is the predominant product (67%) for ICCGt alone, consistent with ICCG-DoT functioning primarily as a PETase cleaving polymer chains. Combined ICCGt + TfCag (Group 2) achieves 1.4× higher TPA production compared to ICCGt alone, confirming synergistic depolymerisation by the dockerin-fused enzyme pair. ScafGVT group (Group 4) shows comparable or slightly higher TPA production with no inhibitory effect.

SCAFFOLD SYNERGY ASSAY — SETUP

Purpose: Directly test whether ScafGVT scaffold has any negative or positive effect on ICCGt PETase activity when co-assembled via cohesin-dockerin interaction

GroupCompositionBuffer (µl)Reaction volume
Va — ICCGt + ScafGVTICCGt 100 mU (35.997 µl, 2nd Gen) + ScafGVT 1 µg (2.98 µl)961.021 mL in 2 mL tube
Vb — ICCGt only (control)ICCGt 100 mU (35.997 µl)964.001 mL in 2 mL tube
Vc — ICCG(No-T)+ScafGVTICCG (no dockerin) 100 mU + ScafGVT 1 µg995.001 mL
Vd — ICCG(No-T) onlyICCG (no dockerin) 100 mU997.931 mL

Temperature: 50°C, 230 rpm

Sampling time points: 24, 48, 72, 96 hr

Reaction start time: Reaction initiated at 17:40

Saturday, June 14, 2026 · Day 13 · Scaffold Synergy Assay — 24 hr Sample; TfCaWA-DoG Cloning

OVERVIEW

Collected 24 hr scaffold synergy assay samples. Initiated cloning of TfCaWA-DoG (double mutant: I69W + V376A), the engineered MHETase variant with enhanced substrate specificity. PCR amplification of mutant insert fragments by Infusion cloning strategy.

SCAFFOLD SYNERGY ASSAY — 24 HR SAMPLING

Sampling time: 17:40 + 24 hr = 17:40 next day

GroupTPA peak area (µV·s)MHET peak area (µV·s)Observation
Va — ICCGt + ScafGVTSimilar to VbSimilar to VbWeak activity at 24 hr
Vb — ICCGt onlyBaselineBaselineLow product at 24 hr; expected at early stage
Vc — ICCG(No-T)+ScafGVTSimilarSimilarSimilar to Vd
Vd — ICCG(No-T) onlyBaselineBaselineNo scaffold effect on unfused enzyme

Observation: 24 hr: Va (ICCGt + ScafGVT) showed weak but comparable activity to Vb (ICCGt alone). No inhibition observed. Vc and Vd (ICCG no-dockerin ± ScafGVT) show similar activity, confirming that ScafGVT does not nonspecifically inhibit PETase activity. Longer incubation required for definitive comparison.

TFCAWA-DOG MUTAGENESIS CLONING — INFUSION STRATEGY

Target construct: pET28a-nosp-TfCaWA-DockerinG-8×His (double mutant: I69W + V376A)

Strategy: Infusion cloning using overlapping PCR fragments (15–40 bp overlap regions)

Primers designed (OPC-purified for GC-rich sequences):

Primer pairPurposeExpected product (bp)Tm (0.4 µM)
28a-XbaI-INFUSION-FP × eTfCa-I69W-RPFragment 1 (I69W mutation region)~245 bp59.4 / 70.1°C
eTfCa-I69W-FP × eTfCa-V376A-RPFragment 2 (V376A mutation region)~933 bp70.1 / 59.4°C
eTfCa-V376A-FP × 28a-EcoRI-INFUSION-RPFragment 3 (C-terminal region)~725 bp67.3 / 64.7°C

PCR polymerase: Pfu (high-fidelity) for long-range mutagenesis; 12× cycles to reduce error rate

Thermocycling: 95°C 1 min → 30× [95°C 15s / 58°C 15s / 72°C 30s/kb] → 72°C 5 min → 12°C ∞

Observation: All three PCR fragments amplified successfully. Gel electrophoresis confirmed bands at ~245, ~933, and ~725 bp. Infusion assembly reaction set up: 50°C, 15 min. Transformed into E. coli DH5α competent cells.

Sunday, June 15, 2026 · Day 14 · TfCaWA-DoG Colony PCR; Scaffold Synergy Assay — 48 hr Sample

OVERVIEW

Screened TfCaWA-DoG transformant colonies by colony PCR. Collected 48 hr scaffold synergy assay samples. Performed HPLC analysis confirming scaffold no-inhibition result at 48 hr.

TFCAWA-DOG COLONY PCR SCREENING

Vector: pET28a-nosp-TfCaWA-G1-8×His (Infusion construct)

Primers: 28a-XbaI-INFUSION-FP (forward) × T7t (reverse)

Expected product size: ~1,984 bp

Colonies screened: ~24 colonies

ColonyBand at ~1984 bpSequencing resultStatus
C1✓ PositivePendingSelected for sequencing
C2✓ PositiveExtra undesired mutationRejected
C4✓ PositiveExtra undesired mutationRejected
C5✓ PositivePendingSelected for sequencing
C12✓ PositiveI5: ATC→ATT (synonymous, Ile5; acceptable)Accepted ✓
OthersNo bandNegative

Observation: Colony C12 confirmed: the only base mutation found (ATC→ATT at codon 5) is synonymous — it does not change the amino acid (Isoleucine 5 remains Ile). This mutation does not affect protein sequence. C12 selected as the final stock for TfCaWA-DoG expression.

SCAFFOLD SYNERGY ASSAY — 48 HR SAMPLING & HPLC

Sampling time: 17:40 + 48 hr

GroupTPA (relative)MHET (relative)vs. ICCGt aloneConclusion
Va — ICCGt + ScafGVT (1 µg)~44 µM·µg⁻¹~1,000 µM·µg⁻¹Comparable ✓No negative effect
Vb — ICCGt only~41 µM·µg⁻¹~1,000 µM·µg⁻¹Baseline
Vc — ICCG(No-T)+ScafGVTSimilarSimilarComparable ✓Same as Vd
Vd — ICCG(No-T) only~420 µM·µg⁻¹~420 µM·µg⁻¹Baseline

Observation: 48 hr scaffold synergy result: Va (ICCGt + ScafGVT) and Vb (ICCGt only) show similar specific activity toward all three products (BHET, MHET, TPA). No statistically significant inhibition by ScafGVT on ICCG-DoT PETase activity. Vc and Vd similarly show no scaffold effect on unfused ICCG enzyme. This validates the PETosome design concept: cohesin-dockerin assembly does not impair enzyme catalytic function.

Monday, June 16, 2026 · Day 15 · Final Scaffold Synergy Results; Summary & Data Compilation

OVERVIEW

Collected final 72–96 hr scaffold synergy assay samples. Compiled all results and confirmed the complete experimental dataset for the depolymerization component. Prepared data summary table for wiki documentation.

SCAFFOLD SYNERGY ASSAY — 72 & 96 HR FINAL RESULTS

Time PointVa (ICCGt + ScafGVT)Vb (ICCGt only)Conclusion
24 hrWeak, comparableWeak (baseline)No inhibition
48 hr~44 µM·µg⁻¹ (BHET)~41 µM·µg⁻¹ (BHET)No inhibition
72 hrComparableComparableNo inhibition
96 hr~44 µM·µg⁻¹~41 µM·µg⁻¹No significant difference ✓

Observation: Final 96 hr scaffold synergy result: ICCGt + ScafGVT produces no statistically significant difference in specific activity (BHET, MHET, TPA) compared to ICCGt alone across all time points (24–96 hr at 50°C). ScafGVT scaffold is fully compatible with ICCG-DoT PETase catalytic function. This result supports the feasibility of the PETosome assembly.

TWO-WEEK EXPERIMENT SUMMARY

DateDayKey ExperimentKey Result / Observation
June 21ICCG-DoT & ScafGVT expression inductionICCG-DoT induced at OD ~1.8, 0.9 mM IPTG, 37°C; ScafGVT at 16°C, 0.2 mM IPTG
June 32Cell harvest; TfCa-DoG inductionICCG-DoT & ScafGVT harvested; expression level meets requirement; TfCa-DoG induced at 18°C, 5 mM IPTG
June 43Ni-NTA purification of ICCG-DoT & ScafGVT; TfCa-DoG lysisICCG-DoT at 39.9 kDa, ScafGVT at 58.96 kDa enriched in 250 mM elution
June 54SDS-PAGE + Western blot; TfCa-DoG purificationAll three proteins confirmed at predicted MW by Coomassie + anti-His blot
June 65PNPB enzyme activity quantificationICCG-DoT: 1,722 mU/mL; TfCa-DoG: 48,888 mU/mL; ScafGVT: scaffold (no esterase activity)
June 76PET agar plate assay; BHET kinetic assay setupClearing halo confirmed for ICCG-DoT dialysed concentrate; BHET assay started at 17:30
June 87BHET assay 24 hr sampling & HPLCNo significant synergy at 24 hr; TPA:MHET ~1:2 for all active groups
June 98BHET 48–72 hr; APET film assay setup (5 groups)BHET 48 hr: ICCGt+TfCag 11% higher µV·s; APET film started at 50°C, 230 rpm
June 109APET 24 hr; BHET 96 hr final & conclusionAPET 24 hr: almost no peak; BHET 96 hr: ICCGt+TfCag 1.4× TPA vs. ICCGt alone
June 1110APET 48 hr HPLC; MHETase activity comparisonAPET 48 hr: product peaks emerging in Groups 2–4; ScafGVT group comparable to Group 2
June 1211APET 72 hr; MHETase BHET comparison assay72 hr products growing; ICCG-DoT confirmed no MHETase activity; TfCa-DoG confirmed MHETase
June 1312APET 96 hr final HPLC; Scaffold synergy setupMHET 67%, TPA 32%, BHET 1% (ICCGt alone); Group 2: 1.4× TPA; Synergy assay started
June 1413Synergy 24 hr; TfCaWA-DoG mutagenesis cloningSynergy 24 hr: weak comparable; TfCaWA PCR fragments confirmed; C12 accepted (synonymous mutation)
June 1514TfCaWA colony PCR; Synergy 48 hr HPLCC12 sequence verified; Synergy 48 hr: Va ≈ Vb — no inhibition by ScafGVT
June 1615Synergy 72–96 hr final; Data compilationFinal result: ScafGVT no negative effect on ICCG-DoT. PETosome design validated.

Jett's Version: The actual notebook, dated.


The section below is a separate, independently-written draft, produced by a team member outside the main documentation process. Kept here for reference and comparison; not yet fact-checked by team leadership.

Date-stamped entries, including the bad days — on the argument that iGEM judges care about reproducibility, and this is what it looks like when a team actually means it.

Entry 01 · Cloning PETase ORF · first try third try (14 Apr 2026 · clean run)

PCR-amplified PETase ORF from a synthesised gBlock (832 bp). First attempt: a primer-dimer band swamped the signal. Lowering the annealing temperature made it worse. Re-ordering primers with a 3' clamp (G/C lock) worked first time at 65°C. Notebook lesson: when in doubt, the primers are wrong, not the polymerase. Result: a single clean band at ~830 bp, sequence-verified on all 3 colonies, stocked in glycerol at −80°C.

Entry 02 · Ag43 induction · membrane failure (4 May 2026 · the bad day)

Attempted to induce Ag43-PETase with 0.2% arabinose for 4 hours, expecting mass loss but not growth arrest. OD600 at induction was 0.62; after 90 minutes the cultures stopped growing, and by 4 hours two of three flasks were visibly cloudy with lysate. Acridine-orange staining confirmed compromised outer membrane in over 40% of cells. "It looked fine at t=0. It looked terrible at t=2h. We did not see this coming." — lab note. Decision: change anchor system; Lpp-OmpA and INPNC moved to the head of the queue.

Entry 03 · Anchor screen · Lpp-OmpA & INPNC (18 May 2026 · pivot)

Dropped Ag43. Built two fusions in parallel — Lpp-OmpA-PETase and INPNC-PETase — on the reasoning that it wasn't yet known which would be membrane-safe at activity-relevant levels, so running both in parallel produces two real data points instead of guessing.

Entry 04 · Kill-switch escape rate · plate-counting day 1 (3 Jun 2026 · in flight)

Plated 10⁷ CFU of each switch-bearing strain onto selective media at the OFF condition. Day-1 result: the temperature switch showed a ~10⁻⁴ escape rate (acceptable for an unoptimised single switch); the light switch showed ~10⁻³, worse than predicted, hypothesised to be photoreceptor saturation. Joint estimate so far: 10⁻⁵ — contingent on the independence claim holding up.

Continue to Jett's Version of Safety and Security → · Back to Jett's Version of Experiments